Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / CL A
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
7,727,518
-
Shares change
-
+3,668,527
-
Total reported value, excl. options
-
$240,322,086
-
Value change
-
+$114,069,942
-
Number of buys
-
56
-
Number of sells
-
-7
-
Price
-
$31.1
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2017
83 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q3 2017.
REATA PHARMACEUTICALS INC - CL A (RETA) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,727,518 shares
.
Largest 10 shareholders include BlackRock Inc. (896,357 shares), FMR LLC (672,891 shares), Novo Holdings A/S (592,794 shares), EMERALD ADVISERS INC/PA (569,416 shares), VANGUARD GROUP INC (516,446 shares), EMERALD MUTUAL FUND ADVISERS TRUST (473,051 shares), Cormorant Asset Management, LLC (388,574 shares), FRANKLIN RESOURCES INC (250,042 shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (250,000 shares), and JPMORGAN CHASE & CO (228,612 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.